Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP429573.RAjoyK-REYtCPy__FDnnoVLb7R79XJemoPMU_Pby81CwQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP429573.RAjoyK-REYtCPy__FDnnoVLb7R79XJemoPMU_Pby81CwQ130_assertion type Assertion NP429573.RAjoyK-REYtCPy__FDnnoVLb7R79XJemoPMU_Pby81CwQ130_head.
- NP429573.RAjoyK-REYtCPy__FDnnoVLb7R79XJemoPMU_Pby81CwQ130_assertion description "[Together, these data indicate that the IL-11Ralpha is a candidate target for translational clinical trials against advanced and metastatic prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP429573.RAjoyK-REYtCPy__FDnnoVLb7R79XJemoPMU_Pby81CwQ130_provenance.
- NP429573.RAjoyK-REYtCPy__FDnnoVLb7R79XJemoPMU_Pby81CwQ130_assertion evidence source_evidence_literature NP429573.RAjoyK-REYtCPy__FDnnoVLb7R79XJemoPMU_Pby81CwQ130_provenance.
- NP429573.RAjoyK-REYtCPy__FDnnoVLb7R79XJemoPMU_Pby81CwQ130_assertion SIO_000772 14744752 NP429573.RAjoyK-REYtCPy__FDnnoVLb7R79XJemoPMU_Pby81CwQ130_provenance.
- NP429573.RAjoyK-REYtCPy__FDnnoVLb7R79XJemoPMU_Pby81CwQ130_assertion wasDerivedFrom befree-2016 NP429573.RAjoyK-REYtCPy__FDnnoVLb7R79XJemoPMU_Pby81CwQ130_provenance.
- NP429573.RAjoyK-REYtCPy__FDnnoVLb7R79XJemoPMU_Pby81CwQ130_assertion wasGeneratedBy ECO_0000203 NP429573.RAjoyK-REYtCPy__FDnnoVLb7R79XJemoPMU_Pby81CwQ130_provenance.